American Pacific buys ingredient manufacturer

American Pacific is buying the assets of Aerojet Fine Chemicals for $119 million and the assumption of some liabilities. AFC makes active pharmaceutical ingredients and registered intermediates for commercial customers in the pharmaceutical industry. It had $66 million in sales last year. "AFC is a perfect fit for our company," said John R. Gibson, CEO of American Pacific. "It is an attractive, profitable business that complements our existing specialty chemical and energetic product portfolio. This acquisition provides us with a strong presence in fast growing pharmaceutical markets where we can provide customers with value added products and services."

- read this press release for more

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.